Showing 1,512 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

New & experimental hepatitis C treatment

Gilead Provides Update on Hepatitis C Development Programs

Editor's pick
Gilead press release
8 January 2013
New & experimental hepatitis C treatment

Achillion Reports Interim Results on ACH-3102

Editor's pick
Achillion press release
8 January 2013
Access to healthcare

Thai-EU Free Trade Agreement Raises Alarm for People With AIDS

Editor's pick
Inter Press Service
3 January 2013
New & experimental hepatitis C treatment

Medivir announces phase III data for Simeprevir demonstrating efficacy and safety in genotype 1 hepatitis C patients

Editor's pick
Medivir press release
20 December 2012
Clinical trials

Industry Funding Changes Study Results, Research Shows

Editor's pick
University of California press release
20 December 2012
New & experimental HIV treatments

ViiV Files Regulatory Applications for New Integrase Inhibitor Dolutegravir

Editor's pick
AIDSMeds
19 December 2012
New & experimental HIV treatments

ViiV Healthcare announces regulatory submissions for dolutegravir in the EU, US and Canada

Editor's pick
ViiV press release
18 December 2012
Pharmaceutical industry

Breaking Up With Gilead Sciences

Editor's pick
The Street
17 December 2012
Pharmaceutical industry

US: AIDS physician groups tell pharma to lower prices

Editor's pick
Pharmalot
12 December 2012
Access to healthcare

Thailand: Local HIV drugs offer lower prices

Editor's pick
Bangkok Post
10 December 2012
Access to healthcare

Brazil enters new era of co-production of anti-AIDS drugs

Editor's pick
Inter Press Service
10 December 2012
HIV treatment for children & young people

Childhood HIV Risks Becoming Neglected Disease As Fewer Children Born With HIV, Experts Warn

Editor's pick
Kaiser Daily Global Health Policy Report
6 December 2012
Access to healthcare

Advocates to drugmakers: Join Patent Pool or else

Editor's pick
Pharmalot
6 December 2012
Pharmaceutical industry

Copy of ITPC Open letter from activists in EECA about the Galien Prix Award goint to Merck for boceprevir

Editor's pick
GMI Partnership
6 December 2012
Pharmaceutical industry

ITPC Open letter from activists in EECA about the Galien Prix Award goint to Merck for boceprevir

Editor's pick
EATG
6 December 2012
Access to healthcare

UNITAID statement on Johnson & Johnson’s darunavir announcement

Editor's pick
UNITAID press release
5 December 2012
Drug-resistant TB

FDA Advisory Committee recommends accelerated approval of bedaquiline for drug-resistant TB

News
3 December 2012
New & experimental hepatitis C treatment

Telaprevir and VX-222 pair well in interferon-free regimen, VX-135 on the horizon

News
3 December 2012
Starting treatment

TAC welcomes the inclusion of fixed-dose combination medicines in the 2013- 2014 antiretroviral medicines tender

Editor's pick
TAC
30 November 2012
Access to healthcare

SOUTH AFRICA: New ARV tender drops prices, changes treatment

Editor's pick
IRIN Plus News
30 November 2012
Access to healthcare

Canada: Tories block bid to make cheaper medicines for poorer nations

Editor's pick
Globe and Mail
30 November 2012
Finance & funding

South Africa: Country Saves R2.2 Billion in HIV Drug Tender

Editor's pick
AllAfrica
30 November 2012
Starting treatment

South Africa: HIV Patients to Take One ARV Tablet Daily

Editor's pick
AllAfrica
30 November 2012
Access to healthcare

J&J Won't Enforce Patents on HIV Medicine in Africa

Editor's pick
Bloomberg BusinessWeek
30 November 2012